NCT00433693View on ClinicalTrials.gov

Correction Study of R744 in Renal Anemia Patients on Hemodialysis

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

October 31, 2008

Conditions
Hemodialysis Patients
Interventions
DRUG

R744

50μg(i.v.)/2 week until Hb concentration reaches to 11.0g/dL or above, then 25\~300μg(i.v.)/4 week

Trial Locations (6)

Unknown

Chugoku/Shikoku region, Chugoku/Shikoku

Chubu region, Chūbu

Hokkaido/Tohoku region, Hokkaido/Tohoku

Kanto/Koshinetsu region, Kanto/Koshinetsu

Kinki/Hokuriku region, Kinki/Hokuriku

Kyusyu region, Kyusyu

Sponsors
All Listed Sponsors
lead

Chugai Pharmaceutical

INDUSTRY